Brief: Transgene: New Data From Next-Generation Immunotherapy Platforms

Transgene SA

22/06/2020 14:29

June 22 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE PRESENTS PROMISING NEW DATA FROM ITS
NEXT-GENERATION
IMMUNOTHERAPY PLATFORMS AT AACR 2020
    * DATA DEMONSTRATING THAT PREDICTION ALGORITHM USED TO
CUSTOMIZE
TG4050 FOR EACH PATIENT IS ACCURATE AT IDENTIFYING IMMUNOGENIC
CANCER MUTATIONS EVEN AMONG A LARGE SET OF CANDIDATE TUMOR
MUTATIONS
    * RESULTS DEMONSTRATE THAT SPECIFICITY OF OUR APPROACH
OUTPERFORMS
INDUSTRY STANDARD AND ARE EXPECTED TO TRANSLATE IN ENHANCED
ACTIVITY IN PATIENTS

Source text for Eikon:  ID:nBw7rr7g0a 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))